Integrated First-In-Human And Clinical Pharmacology Programs

When you are looking for a partner who is dedicated to Phase I trials and early development, rely on Quotient Sciences. We accelerate your molecule from first-in-human to proof-of-concept, helping you make critical decisions earlier. Whatever clinical pharmacology study you require, you can expect a fully integrated program from study design to data reporting.

We are dedicated to your Phase I study with our:

• Proven track record of more than 30 years
• 1,300+ Phase I studies completed
• Experts in first-in-human (FIH) and drug-drug interaction (DDI) and thorough QT (TQT) studies
• Industry-leading Phase I medical directors
• Ability to recruit large cohorts ofvolunteers
• Fully integrated programs led by experienced project managers
• In-house data sciences team